KFS
ALDX icon

Kelly Financial Services’s Aldeyra Therapeutics ALDX Stock Holding History

Kelly Financial Services’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,507
Closed -$11.1K – 686
2022
Q1 		$11.1K Hold
2,507
– – 0.01% 325
2021
Q4 		$10K Hold
2,507
– – ﹤0.01% 343
2021
Q3 		$22K Sell
2,507
-25,897
-91% -$238K 0.01% 247
2021
Q2 		$2.51M Buy
28,404
+25,897
+1,033% +$311K 0.1% 64
2021
Q1 		$29.8K Hold
2,507
– – 0.02% 181
2020
Q4 		$17.2K Hold
2,507
– – 0.01% 212
2020
Q3 		$18.6K Buy
+2,507
New +$16.2K 0.01% 185

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Kelly Financial Services's ALDX Position: Q2 2022 in Review

Kelly Financial Services sold out of Aldeyra Therapeutics (ALDX) in Q2 2022, closing a stake of 2,507 shares — an estimated $11.1K sold.

Kelly Financial Services first reported a position in ALDX in Q3 2020 and held it in 7 quarters. The position peaked at $2.51M in Q2 2021. 95 funds tracked by Wall St. Rank hold ALDX as of Q2 2022.

  • Kelly Financial Services reported no remaining Aldeyra Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Kelly Financial Services sold 2,507 Aldeyra Therapeutics shares in Q2 2022, an estimated $11.1K.
  • Kelly Financial Services first reported a position in Aldeyra Therapeutics in Q3 2020 and held it in 7 quarters.
  • Kelly Financial Services's Aldeyra Therapeutics position peaked at $2.51M in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2022.

Based on Kelly Financial Services's 13F filing for Q2 2022, filed 17 Jul 2024.